Get the Stockscreener App
5.19
3.53%
-0.19
Bionexus Gene Lab Corp stock is traded at $5.19, with a volume of 28,106.
It is down -3.53% in the last 24 hours and up +18.76% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$5.38
Open:
$5.39
24h Volume:
28,106
Relative Volume:
0.03
Market Cap:
$9.32M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-72.08
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
-1.89%
1M Performance:
+18.76%
6M Performance:
+139.17%
1Y Performance:
+23.87%
1-Day Range:
$5.17
$5.4999
1-Week Range:
$5.14
$5.59
52-Week Range:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
4.00 | 5.77B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.00 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.63 | 109.81M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.21 | 439.54M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.93 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
Why BioNexus Gene Lab Corp. stock could outperform in 20252025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Real time pattern detection on BioNexus Gene Lab Corp. stockWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Is a relief rally coming for BioNexus Gene Lab Corp. holdersJuly 2025 Big Picture & Safe Entry Point Identification - newser.com
Published on: 2025-10-09 05:38:27 - newser.com
What recovery options are there for BioNexus Gene Lab Corp.2025 Momentum Check & Smart Money Movement Tracker - newser.com
How hedge fund analytics apply to BioNexus Gene Lab Corp. stockTrade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
Candlestick signals on BioNexus Gene Lab Corp. stock todayJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-10-06 00:51:58 - newser.com
How buybacks impact BioNexus Gene Lab Corp. stock valueEarnings Summary Report & Weekly High Potential Stock Alerts - newser.com
How to build a dashboard for BioNexus Gene Lab Corp. stockWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
Published on: 2025-10-03 01:13:20 - newser.com
How analysts rate BioNexus Gene Lab Corp. stock todayPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Is BioNexus Gene Lab Corp. meeting your algorithmic filter criteriaAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Published on: 2025-09-29 02:28:49 - newser.com
What analysts say about BioNexus Gene Lab Corp stockRisk-Reward Ratio Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Published on: 2025-09-29 02:08:22 - earlytimes.in
BioNexus Gene Lab Corp Stock Analysis and ForecastIndustrial Stocks Review & Smart Beta Strategies That Actually Work - earlytimes.in
What drives BioNexus Gene Lab Corp stock priceMarket Breadth Indicators & Unlock Smart Investment Tactics That Work - earlytimes.in
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.88%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):